Company · Bangalore, Karnataka, India
Micro Labs Limited
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 7
- 7 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 7
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| BRIMONIDINEStatus since Sep 2023 | 02540673 | Approved | |
| BRIMONIDINE-TIMOLOLStatus since Aug 2026 | 02570769 | Approved | |
| DORZOLAMIDEStatus since Jun 2022 | 02528169 | Approved | |
| DORZOLAMIDE PFStatus since Oct 2023 | 02542110 | Approved | |
| DORZOLAMIDE-TIMOLOLStatus since Jun 2022 | 02528215 | Approved | |
| DORZOLAMIDE-TIMOLOL PFStatus since Oct 2023 | 02542056 | Approved | |
| TIMOLOL MALEATE OPHTHALMIC SOLUTIONStatus since Nov 2024 | 02553287 | Approved |
Notices of Compliance
Newest first.
- BRIMONIDINE-TIMOLOLAugust 12, 2026 · NOC 38112 · Abbreviated New Drug Submission (ANDS)
- TIMOLOL MALEATE OPHTHALMIC SOLUTIONNovember 22, 2024 · NOC 34437 · Abbreviated New Drug Submission (ANDS)
- DORZOLAMIDE PFOctober 31, 2023 · NOC 32011 · Abbreviated New Drug Submission (ANDS)
- DORZOLAMIDE-TIMOLOL PFOctober 25, 2023 · NOC 31932 · Abbreviated New Drug Submission (ANDS)
- BRIMONIDINESeptember 1, 2023 · NOC 31540 · Abbreviated New Drug Submission (ANDS)
- DORZOLAMIDEJune 24, 2022 · NOC 28463 · Abbreviated New Drug Submission (ANDS)
- DORZOLAMIDE-TIMOLOLJune 23, 2022 · NOC 28461 · Abbreviated New Drug Submission (ANDS)